Insulin degludec and insulin glargine 300 U/mL: Which of these two insulins causes less hypoglycemia?

J Diabetes Investig. 2019 Nov;10(6):1595-1596. doi: 10.1111/jdi.13065. Epub 2019 May 28.

Authors

Silvio Buscemi¹, Cristiana Randazzo¹, Carola Buscemi²

Affiliations

¹ Unit of Endocrinology, Metabolic and Nutrition Diseases, University Hospital Policlinico "P. Giaccone" - University of Palermo, Palermo, Italy.
² Unit of Geriatrics, Garibaldi-Nesima Hospital, Postgraduate School of Geriatrics, University of Catania, Catania, Italy.

Abstract

Insulin degludec versus insulin glargine 300 U/mL.

Publication types

Letter

MeSH terms

Humans
Hypoglycemia / blood*
Hypoglycemia / chemically induced
Hypoglycemic Agents / adverse effects
Hypoglycemic Agents / therapeutic use*
Insulin Glargine / adverse effects
Insulin Glargine / therapeutic use*
Insulin, Long-Acting / adverse effects
Insulin, Long-Acting / therapeutic use*

Substances

Hypoglycemic Agents
Insulin, Long-Acting
Insulin Glargine
insulin degludec